News Sentiment

ATHE sentiment intelligence

Alterity Therapeutics Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.98 Week of 17 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

82/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

-8.3% over one week, +2.0% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026

Market Reaction

Price moving ahead of tone

67/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 82/100 classification
One-week reaction -8.3% Price reacting lower
Trend fit Trend active 2.0% over four weeks
Fair value 61.5% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 14
Neutral 33
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 9
Stock Titan 9
TradingView 7
Kalkine 7
GlobeNewswire 5
Moomoo 4
Kalkine Media 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 14
Analyst action 2
Balance sheet 2
Regulatory and legal 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49
TradingView Direct company coverage

Alteriry Therapeutics Ltd Sponsored ADR Actuals & Estimates (NASDAQ:ATHE)

This article provides access to the financial actuals and estimates for Alterity Therapeutics Limited (NASDAQ: ATHE) via TradingView. It allows users to explore reported financial data and analyst estimates across various financial statements and valuation metrics. The platform e

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 14:39
Source
TradingView
TradingView Direct company coverage

Equity in earnings of Alterity Therapeutics Ltd Warrant 2023-31.08.26 on Alterity/Deferred Delivery – ASX:ATHDB

This article displays the "Equity in earnings" section for Alterity Therapeutics Ltd Warrant 2023-31.08.26, traded on the Australian Securities Exchange under the ticker ATHDB. It provides a financial overview, though no specific data is presented in the provided content as the m

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 05:11
Source
TradingView